Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

This publication has 9 references indexed in Scilit:

• Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs
  British Journal of Cancer, 1998
• Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)
  British Journal of Cancer, 1997
• Immunomodulatory Actions of Xanthenone Anticancer Agents
  BioDrugs, 1997
• Induction of tumour necrosis factor-? by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid
  Cancer Chemotherapy and Pharmacology, 1995
• Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids
  Journal of Medicinal Chemistry, 1991
• Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.
  Proceedings of the National Academy of Sciences, 1989
• Flavone acetic acid—Preclinical and clinical activity
  European Journal of Cancer and Clinical Oncology, 1989
• The Effect of Several Different Anaesthetics on the Blood Pressure and Heart Rate of the Mouse and on the Radiation Response of the Mouse Sarcoma RIF-1
  International Journal of Radiation Biology, 1985